Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am Surg ; 89(4): 961-967, 2023 Apr.
Article in English | MEDLINE | ID: mdl-34732061

ABSTRACT

BACKGROUND: While Botox sphincterotomy with or without fissurectomy has been proven effective in healing anal fissures, they have not been directly compared. We evaluated cost-effectiveness and outcomes between Botox sphincterotomies with and without fissurectomy. METHODS: A 5-year retrospective review was conducted comparing all patients undergoing Botox sphincterotomy for anal fissure with or without fissurectomy. Outcomes including recurrence/persistence, additional treatments, complications, and total charges were compared between study groups. RESULTS: Patients treated without fissurectomy (n = 53) had recurrent/persistent fissure more often (56.6 vs 31.0%, P = .001), and required more Botox treatments. Those treated with fissurectomy (n = 154) had more complications (13.5 vs 0%, P = .003). Patients initially treated without fissurectomy had a median total charge of $2 973, while median total charge for those initially treated with fissurectomy was $17 925 (P < .001). CONCLUSIONS: Botox sphincterotomy in an office without fissurectomy is a viable option. It may result in longer healing times but is associated with reduced cost, lower complication rates, and no need for anesthesia or operative intervention in most cases. But the choice of treatment route must be individualized.


Subject(s)
Botulinum Toxins, Type A , Fissure in Ano , Humans , Botulinum Toxins, Type A/therapeutic use , Anal Canal/surgery , Chronic Disease , Fissure in Ano/drug therapy , Fissure in Ano/surgery , Wound Healing , Treatment Outcome
2.
Surg Clin North Am ; 97(3): 641-656, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28501252

ABSTRACT

Primary colorectal lymphoma, carcinoids (neuroendocrine tumors), and gastrointestinal stromal tumors comprise a small subset of all colorectal cancers. Their features are unique, and their treatment varies from that of colorectal adenocarcinoma. Appropriate identification is key in the management of these tumors.


Subject(s)
Colorectal Neoplasms , Gastrointestinal Stromal Tumors , Neuroendocrine Tumors , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/mortality , Colorectal Neoplasms/therapy , Gastrointestinal Stromal Tumors/diagnosis , Gastrointestinal Stromal Tumors/therapy , Humans , Neuroendocrine Tumors/diagnosis , Neuroendocrine Tumors/therapy , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...